PREVALENCE OF HEPATITIS A VIRUS, HEPATITIS B VIRUS, AND HEPATITIS C VIRUS, AMONG PATIENTS WITH HEPATIC JAUNDICE IN SANA’A CITY, YEMEN: A HOSPITAL BASED STUDY

  • Huda Zaid Al-Shami Medical Microbiology and Clinical Immunology Department, Faculty of Medicine and Health Sciences, Sana’a University, Republic of Yemen.
  • Zaid Ali Mohammed Al-Mutawakal Medical Microbiology and Clinical Immunology Department, Faculty of Medicine and Health Sciences, Sana’a University, Republic of Yemen.
  • Abdulwahab Ismail Mohamed Al-Kholani Department of conservative dentistry, Faculty of Dentistry, Sana’a University, Republic of Yemen.
  • Muhamed Ahmed Al-Haimi Departement of Medicine, Faculty of Medicine and Health Sciences, Sana’a University, Republic of Yemen.
  • Ahmed Mohammed Al-Haddad Department of Medical Laboratories, College of Medicine and Health Sciences, Hadhramout University, Al-Mukalla, Yemen.
  • Redhwan A. Ahmed Medical Microbiology and Clinical Immunology Department, Faculty of Medicine and Health Sciences, Sana’a University. Laboratory Department, University of Science and Technology Hospital, Sana'a, Yemen.
  • Ali Abdullah Al-Somainy Medical Microbiology and Clinical Immunology Department, Faculty of Medicine and Health Sciences, Sana’a University. The National Center for Public Health Laboratories in Sana'a, The Ministry of Health and Population, Sana’a, Yemen.
  • Hassan Abdulwahab Al-Shamahy Medical Microbiology and Clinical Immunology Department, Faculty of Medicine and Health Sciences, Sana’a University. Medical Microbiology department, Faculty of Medicine, Genius University for Sciences & Technology, Dhamar city, Republic of Yemen.
10.22270/ujpr.v6i6.693

Keywords:

Hepatic jaundice, Hepatitis A virus, Hepatitis B virus, Hepatitis C virus, prevalence, Sana’a, viral hepatitis, Yemen

Abstract

Background: Hepatic jaundice results from abnormal metabolism of bilirubin in the liver. The main hepatic jaundice causes are severe damage to hepatocytes due to autoimmune diseases, infectious diseases, drugs/ medication induced, or, less commonly, hereditary genetic diseases.

Aim: The aim of this study is to determine the prevalence of hepatitis B Virus (HBV), hepatitis A virus (HAV), and hepatitis C virus (HCV), in patients with hepatic jaundice as causes of acute viral hepatitis (AVH) in Sana'a city, Yemen.

Subjects and Methods: Data of patients with hepatic jaundice tested for hepatitis B surface antigen, total anti-HCV antibody, and anti-HAV immunoglobulin M (IgM) by enzyme-linked immunosorbent assay were collected from Class I Viral Diagnostic Laboratories in Sana'a for 3 years. Then the statistical analysis of the data was used where the descriptive analysis was calculated: frequency and percentage, as well as the association of infection with sex and age group by means of detection odds ratio, 95% CI and X2 more than 3.9 and P<0.05 were considered statistically significant.

Results: The study included 644 males (43.8%) and 826 females (56.2%), while most patients were less than 21 years old. The rate of Hepatitis viruses positive was 27.6% positive. Hepatitis A virus infection was the most common virus diagnosed accounting for 259 cases (17.6% of the total), while HBV was less common with 104 (7.1%) and HCV only 42 cases (2.9%). The highest incidence of hepatitis B was in 11-20 years patients (18.2%), with an associated OR 9.3 (p < 0.0001). The highest incidence of hepatitis C was in 31-40 years patients (7.3%), with an associated OR 3.3 (p<0.0001).

Conclusion:  Alarmingly changing the epidemiology and dynamics of hepatitis A-C viruses in Yemen, a detailed study is required to understand the definite disease problem caused by these viruses. It is noticeable in this study the high prevalence of hepatitis A virus and hepatitis B virus in the Yemeni population with hepatic jaundice. Also, to our knowledge, this study is the first to report epidemiological transformation of hepatitis A virus in Sana'a, Yemen.

                    r38.gif

Peer Review History:

Received: 1 October 2021; Revised: 6 November; Accepted: 9 December; Available online: 15 January 2022

Academic Editor: Dr. Nuray Arıorcid22.jpg, Ankara University, Turkiye, ari@ankara.edu.tr

Received file:blue_23983.gif                Reviewer's Comments:download_logo_r_29189.gif

Average Peer review marks at initial stage: 5.5/10

Average Peer review marks at publication stage: 7.0/10

Reviewers:

orcid22.jpgDr. Gulam Mohammed Husain,, National Research Institute of Unani Medicine for Skin Disorders, Hyderabad, India, gmhusain@gmail.com

orcid22.jpgDr. Salfarina Ramli, Department of Pharmacology and Pharmaceutical Chemistry, Faculty of Pharmacy, Universiti Teknologi MARA, 42300 Puncak Alam, Selangor, Malaysia. salfarina2892@uitm.edu.my  

Downloads

Download data is not yet available.
Crossmark
Statistics
703 Views | 151 Downloads
Dimension Citations

Published

2022-01-15

How to Cite

Al-Shami, H. Z., Z. A. M. Al-Mutawakal, A. I. M. Al-Kholani, M. A. Al-Haimi, A. M. Al-Haddad, R. A. Ahmed, A. A. Al-Somainy, and H. A. Al-Shamahy. “PREVALENCE OF HEPATITIS A VIRUS, HEPATITIS B VIRUS, AND HEPATITIS C VIRUS, AMONG PATIENTS WITH HEPATIC JAUNDICE IN SANA’A CITY, YEMEN: A HOSPITAL BASED STUDY”. Universal Journal of Pharmaceutical Research, vol. 6, no. 6, Jan. 2022, doi:10.22270/ujpr.v6i6.693.

Issue

Section

Research Articles
Share |

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 > >> 

Similar Articles

You may also start an advanced similarity search for this article.